Images are for illustrative purposes only.
Cartalax
Cartalax is the tripeptide Ala-Glu-Asp (AED), molecular weight approximately 333 Da, developed from research into cartilage-derived peptide fractions. It is proposed to modulate gene expression in chondrocytes, the cell type responsible for synthesizing and maintaining cartilage extracellular matrix.
Cartalax occupies a distinctive structural position in the series: AED is the exact three-residue core that Epitalon (AEDG), Bronchogen (AEDL), Cardiogen (AEDR), and Cortagen (AEDP) each extend by a single fourth residue. Cartalax is that core on its own, making it the smallest member of the AED family and a frequent reference point in structure-activity discussions of the class. It is also the only bioregulator in the series oriented toward cartilage and joint tissue. In vitro and animal studies examine chondrocyte activity, proteoglycan and extracellular-matrix synthesis signaling, and joint-tissue gene expression.
Supplied as a lyophilized 10-vial 20mg kit for in vitro research use only.